Related Experiment Video
Updated: May 24, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
HPV vaccination coverage within 3 years of program launching (2008-2011) at Geneva State, Switzerland
Emilien Jeannot1, Philippe Sudre, Philippe Chastonay
1Faculty of Medicine, Institute of Social and Preventive Medicine, University of Geneva, Geneva, Switzerland. emilien.jeannot@unige.ch
Objective:
The objective of this study is to assess the HPV vaccination coverage of 11-19-year-old girls during a state-coordinated HPV vaccination program in Geneva, Switzerland, from September 2008 to June 2011.
Methods:
State Medical Office coordinated the HPV vaccination program. Each service provider transmitted the list of the persons who had received their first, second, or third shot.
Results:
The global coverage rates, 3 years after the program had been launched, were 63.72% for one dose, 63.22% for two doses, and 61.40% for three doses of the HPV vaccine.
Conclusion:
This study shows that it is possible to obtain a good coverage rates after 3 years of a state-coordinated HPV vaccination program.
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
02:59Cancer Prevention
Some...